Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05777655 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Improving Adherence to Statin Therapy Through a Medication Management Application

Study acronym: STAPP
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Notable Primary completion date: Feb 28, 2026 to Feb 28, 2028
    • Study completion date: Feb 28, 2027 to Nov 28, 2028
    v3
  2. Notable Primary completion date: Feb 28, 2025 to Feb 28, 2026v2
  3. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Interventional study to compare standard of care vs standard of care plus the use of a medication therapy management smartphone app (mediteo m+, Mediteo GmbH, Heidelberg) in patients with atherosclerotic cardiovascular disease and indication to start high intensity statin therapy.
Trial Details
NCT Number NCT05777655
Lead Sponsor University Hospital, Essen
Conditions
(from sponsor)
Atherosclerosis
Related terms Atherosclerosis
Enrollment 250 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov